1
0
0
News
Professor Heikki Joensuu has been appointed ViceGlobeNewswire
www.globenewswire.com
Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher. Joensuu joins Orion from the Comprehensive Cancer Center, Helsinki University Hospital ... Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher. Joensuu joins Orion from the Comprehensive Cancer Center, Helsinki University Hospital ...
Heikki Joensuu awarded for 30 years of cancer researchCancer Society of Finland
www.cancersociety.fi
— The Cancer Foundation Finland awards the Niilo Voipio Prize for Professor Heikki Joensuu. For almost 30 years Joensuu has contributed to the — The Cancer Foundation Finland awards the Niilo Voipio Prize for Professor Heikki Joensuu. For almost 30 years Joensuu has contributed to the ...
ESMO announces Hamilton Fairley Award recipient as ...ecancer
ecancer.org
— The European Society for Medical Oncology (ESMO) has announced the winner of this year's Hamilton Fairley Award as Heikki Joensuu from — The European Society for Medical Oncology (ESMO) has announced the winner of this year's Hamilton Fairley Award as Heikki Joensuu from ...
Newsecancer
ecancer.org
ESMO announces Hamilton Fairley Award recipient as Heikki Joensuu. ESMO announces Hamilton Fairley Award recipient as Heikki Joensuu.
Netzwerk-Profile
LinkedIn: Beitrag von Heikki Joensuu
Beitrag von Heikki Joensuu. Profil von Heikki Joensuu anzeigen, Grafik · Heikki Joensuu. Senior Project Manager at Serres Oy. 5 Jahre Bearbeitet. Beitrag von Heikki Joensuu. Profil von Heikki Joensuu anzeigen, Grafik · Heikki Joensuu. Senior Project Manager at Serres Oy. 5 Jahre Bearbeitet.
Interessen
'Intriguing': 9 Weeks of Trastuzumab for Breast CancerMedscape
www.medscape.com
— Lead investigator Heikki Joensuu, MD, of the University of Helsinki in Finland, was clear about the meaning of the results: "Chemotherapy — Lead investigator Heikki Joensuu, MD, of the University of Helsinki in Finland, was clear about the meaning of the results: "Chemotherapy ...
Adjuvant Docetaxel or Vinorelbine with or without ...The New England Journal of Medicine
www.nejm.org
von H Joensuu · · Zitiert von: — Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer. Authors: Heikki Joensuu, M.D., Pirkko-Liisa Kellokumpu ... von H Joensuu · · Zitiert von: — Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer. Authors: Heikki Joensuu, M.D., Pirkko-Liisa Kellokumpu ...
Risk of recurrence of gastrointestinal stromal tumour after ...The Lancet
www.thelancet.com
Prof Heikki Joensuu, MD, Aki Vehtari, DSci, Jaakko Riihimäki, MSc, Toshirou Nishida, MD, Sonja E Steigen, MD, Peter Brabec, MSci, Prof Lukas Plank, MD ... Prof Heikki Joensuu, MD, Aki Vehtari, DSci, Jaakko Riihimäki, MSc, Toshirou Nishida, MD, Sonja E Steigen, MD, Peter Brabec, MSci, Prof Lukas Plank, MD ...
Efficacy and Safety of Imatinib Mesylate in Advanced ...The New England Journal of Medicine
www.nejm.org
... Heikki Joensuu, M.D. -13Author Info & Affiliations. Published August 15, N Engl J Med 2002;347: DOI: NEJMoa VOL NO Heikki Joensuu, M.D. -13Author Info & Affiliations. Published August 15, N Engl J Med 2002;347: DOI: NEJMoa VOL NO
Ausbildung
Academy of Europe: CV - Heikki JoensuuAcademy of Europe
www.ae-info.org
— Heikki Joensuu was one of the founders of the Finnish Breast Cancer Group in the 1990's, and has since then acted as a Principal Investigator in — Heikki Joensuu was one of the founders of the Finnish Breast Cancer Group in the 1990's, and has since then acted as a Principal Investigator in ...
| Finland Times
www.finlandtimes.fi
Professor Heikki Joensuu. Photo – Lehtikuva. The European Society for Medical Oncology (ESMO) has announced University of Helsinki ...
Promis, Sportler & Politiker
Heikki Joensuu DiscographyDiscogs
www.discogs.com
Explore music from Heikki Joensuu. Shop for vinyl, CDs, and more from Heikki Joensuu on Discogs. Explore music from Heikki Joensuu. Shop for vinyl, CDs, and more from Heikki Joensuu on Discogs.
Herkunft
Juho Joensuu - Historical records and family treesMyHeritage
www.myheritage.com
Juho Heikki Joensuu was born in Juho married Maria Sofia Joensuu . Juho was buried in ... Juho Heikki Joensuu was born in Juho married Maria Sofia Joensuu . Juho was buried in ...
Bücher
Heikki Joensuu | University of Helsinki | 607 PublicationsAI Chat for scientific PDFs | SciSpace
typeset.io
Heikki Joensuu is an academic researcher from University of Helsinki. The author has contributed to research in topics: Breast cancer & Cancer. Heikki Joensuu is an academic researcher from University of Helsinki. The author has contributed to research in topics: Breast cancer & Cancer.
Cancer Treatment Reportsgoogle.com
books.google.com
Effect of Tamoxifen on Immune Functions1 Heikki Joensuu , * Auli Toivanen ... Heikki Joensuu , MD , Department of Radiother- apy , University Central ...
Journal of the National Cancer Institutegoogle.com
books.google.com
... Heikki Joensuu , MD , Department of Oncology , Helsinki University Central Hospital , Haartmaninkatu 4 , FIN Helsinki , Finland ( e - mail : heikki ...
Medinfo - Seite Google Books-Ergebnisseitegoogle.com
books.google.com
... Heikki Joensuu * Department of Oncology , University of Helsinki , Helsinki , Finland b Institute of Medical Technology , University of Tampere and Tampere ...
Dokumente zum Namen
SPARK in the Valley of Death, Heikki Joensuu, Helsinki ...SlideShare
www.slideshare.net
— SPARK in the Valley of Death, Heikki Joensuu, Helsinki University Hospital. - Download as a PDF or view online for free — SPARK in the Valley of Death, Heikki Joensuu, Helsinki University Hospital. - Download as a PDF or view online for free.
Different opinions on classification of DNA histograms ...Wiley Online Library
onlinelibrary.wiley.com
von H Joensuu · · Zitiert von: 87 — Heikki Joensuu,. Heikki Joensuu. Department of Radiotherapy, Turku University Central Hospital, Turku, Finland. Search for more papers by this author · Olli ... von H Joensuu · · Zitiert von: 87 — Heikki Joensuu,. Heikki Joensuu. Department of Radiotherapy, Turku University Central Hospital, Turku, Finland. Search for more papers by this author · Olli ...
Heikki JoensuuAmerican Society of Clinical Oncology
meetings.asco.org
Presenter: Heikki Joensuu, MD. article Abstracts · slideshow Videos · filter_none Slides. Abstracts & Presentations ASCO Annual ... Presenter: Heikki Joensuu, MD. article Abstracts · slideshow Videos · filter_none Slides. Abstracts & Presentations ASCO Annual ...
Anagrelide for Gastrointestinal Stromal Tumor - AACR Journalsaacrjournals.org
aacrjournals.org
von OP Pulkka · · Zitiert von: 17 — Heikki Joensuu. Heikki Joensuu *. 1Laboratory of Molecular Oncology, Research Programs Unit, Translational Cancer Biology, Department of Oncology ... von OP Pulkka · · Zitiert von: 17 — Heikki Joensuu. Heikki Joensuu *. 1Laboratory of Molecular Oncology, Research Programs Unit, Translational Cancer Biology, Department of Oncology ...
Wissenschaftliche Veröffentlichungen
Trastuzumab emtansine: mechanisms of action and drug ...Breast Cancer Research
breast-cancer-research.biomedcentral.com
von M Barok · · Zitiert von: 635 — Trastuzumab emtansine: mechanisms of action and drug resistance. Mark Barok,; Heikki Joensuu &; Jorma Isola. Breast Cancer Research volume ... von M Barok · · Zitiert von: 635 — Trastuzumab emtansine: mechanisms of action and drug resistance. Mark Barok,; Heikki Joensuu &; Jorma Isola. Breast Cancer Research volume ...
New Radiation Therapy Treatment Developed For Head ...ScienceDaily
www.sciencedaily.com
— ... Heikki Joensuu. "The current treatment is a result of a long period of research, a proof of academic expertise, and a model for effective — ... Heikki Joensuu. "The current treatment is a result of a long period of research, a proof of academic expertise, and a model for effective ...
Veröffentlichungen allgemein
Heikki Joensuu - WikidataWikipedia
www.wikidata.org
Heikki Joensuu. researcher. In more languages. Spanish. Heikki Joensuu. investigador. Traditional Chinese. No label defined. No description defined. Chinese. No ... Heikki Joensuu. researcher. In more languages. Spanish. Heikki Joensuu. investigador. Traditional Chinese. No label defined. No description defined. Chinese. No ...
Emerging Agents for the Treatment of Advanced, Imatinib-Resistant...
link.springer.com
Sebastian Bauer (1) (2); Heikki Joensuu · (3). Author Affiliations. 1. Sarcoma Center, West German Cancer Center, ...
Video & Audio
Heikki JoensuuYouTube
www.youtube.com
Heikki Joensuu. @heikkijoensuu subscribers•8 videos. More about this channel ...more ...more. Subscribe. Home. Videos. Shorts. Search. Shorts ... Heikki Joensuu. @heikkijoensuu subscribers•8 videos. More about this channel ...more ...more. Subscribe. Home. Videos. Shorts. Search. Shorts ...
INVICTUS trial: positive results for patients with GISTESMO Daily Reporter
dailyreporter.esmo.org
According to Heikki Joensuu, Helsinki University Central Hospital, Helsinki, Finland, results are surprisingly good in this difficult to treat population of ... According to Heikki Joensuu, Helsinki University Central Hospital, Helsinki, Finland, results are surprisingly good in this difficult to treat population of ...
Phase III trial data supports current standard 12-month ...ecancer
ecancer.org
Prof Heikki Joensuu - University of Helsinki, Helsinki, Finland. Prof Joensuu speaks at a SABCS press session about data from the phase ...
Artikel & Meinungen
Twitter-Nachrichten: CSF Cancer SocietyX · CancerFinland1 „Gefällt mir“-Angabe · vor 7 Jahren
Researcher, Professor Heikki Joensuu gives a speech on #cancer and how the fight against it could be won. #SSY80. Researcher, Professor Heikki Joensuu gives a speech on #cancer and how the fight against it could be won. #SSY80.
Wikipedia: Heikki Joensuu – Wikipedia
Heikki Joensuu (s Turku) on suomalainen lääkäri ja syöpätutkija. Hänen johdollaan on tutkittu kasvaintyyppiä gist (gastrointestinaalinen stroomatuumori).
Adjuvant treatment of GIST: patient selection and treatment...
www.nature.com
Tyrosine kinase inhibitors, such as imatinib, are effective treatments of advanced-stage gastrointestinal stromal tumour. Here, the optimal treatment strategy...
Sonstiges
Dr. Heikki Joensuu ArchivesThe Life Raft Group
liferaftgroup.org
updated The GIST Risk Calculator is based on research from Dr. Heikki Joensuu, Professor of Oncology at the University of Helsinki and the Research ... updated The GIST Risk Calculator is based on research from Dr. Heikki Joensuu, Professor of Oncology at the University of Helsinki and the Research ...
Heikki Joensuu - University of Helsinki Research PortalHelsinki.fi
researchportal.helsinki.fi
Heikki Joensuu · Puhelin · , . Heikki Joensuu · Puhelin · , .
Heikki Joensuu email address & phone numberRocketReach
rocketreach.co
Heikki Joensuu, based in Versailles, FR, is currently a Director, Remote Sensing and AviMet at Vaisala, bringing experience from previous roles at Vaisala ... Heikki Joensuu, based in Versailles, FR, is currently a Director, Remote Sensing and AviMet at Vaisala, bringing experience from previous roles at Vaisala ...
Heikki Joensuu's research works | University of Helsinki ...ResearchGate
www.researchgate.net
Heikki Joensuu's 585 research works with citations and reads, including: BRIEF COMMUNICATION Tumor infiltrating lymphocyte stratification of ... Heikki Joensuu's 585 research works with citations and reads, including: BRIEF COMMUNICATION Tumor infiltrating lymphocyte stratification of ...
Heikki Joensuu: Medicine H-index & AwardsResearch.com
research.com
Heikki Joensuu ; Cancer; Internal medicine; Gene ; Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (3544 citations); Kinase ... Heikki Joensuu ; Cancer; Internal medicine; Gene ; Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (3544 citations); Kinase ...
Heikki Joensuu: Positions, Relations and Networkmarketscreener.com
in.marketscreener.com
Heikki Joensuu is currently the Vice President-Therapy Area Oncology, R&D at Orion Oyj since Prior to this, he worked as the Scientific Director at ... Heikki Joensuu is currently the Vice President-Therapy Area Oncology, R&D at Orion Oyj since Prior to this, he worked as the Scientific Director at ...
Orion Corporation appoints Professor Heikki Joensuu as ...The Free Library
www.thefreelibrary.com
Free Online Library: Orion Corporation appoints Professor Heikki Joensuu as VP of Therapy area Oncology, R&D. by "M2 EquityBites (EQB)"; Business Executives ... Free Online Library: Orion Corporation appoints Professor Heikki Joensuu as VP of Therapy area Oncology, R&D. by "M2 EquityBites (EQB)"; Business Executives ...
Prof. Heikki Joensuu M.D., Ph.D. Net Worth (2024)Wallmine
de.wallmine.com
Prof. Heikki Joensuu M.D., Ph.D. is the R&D Global Head of Therapy Area Oncology at Orion Oyj. Prof. Heikki Joensuu M.D., Ph.D. is the R&D Global Head of Therapy Area Oncology at Orion Oyj.
Heikki Joensuu Academia Europaean jäseneksiHUS
www.hus.fi
— Syöpäkeskuksen osastonylilääkäri, professori Heikki Joensuu on valittu Academia Europaean jäseneksi — Syöpäkeskuksen osastonylilääkäri, professori Heikki Joensuu on valittu Academia Europaean jäseneksi.
Professor Heikki Joensuu Has Been Appointed Vice ...BioSpace
www.biospace.com
— Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher. Joensuu joins Orion from the Comprehensive Cancer Center, Helsinki — Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher. Joensuu joins Orion from the Comprehensive Cancer Center, Helsinki ...
Professor Heikki Joensuu appointed as VP of Oncology ...Spark Finland
sparkfinland.fi
— Professor Heikki Joensuu, M.D., Ph.D., has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation as of 1 December — Professor Heikki Joensuu, M.D., Ph.D., has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation as of 1 December ...
Professori Heikki Joensuu nimitetty onkologian terapia ...Orion Corporation
www.orion.fi
— Heikki Joensuu (synt ) on suomalainen syöpälääkäri ja -tutkija. Joensuu siirtyy Orionille HYKS Syöpäkeskuksesta (Comprehensive Cancer — Heikki Joensuu (synt ) on suomalainen syöpälääkäri ja -tutkija. Joensuu siirtyy Orionille HYKS Syöpäkeskuksesta (Comprehensive Cancer ...
Your search for Heikki Joensuu, MD, PhD matches 3 pagesThe ASCO Post
ascopost.com
— As reported in the Journal of Clinical Oncology by Heikki Joensuu, MD, PhD, of the Comprehensive Cancer Center Helsinki, Finland, and colleagues — As reported in the Journal of Clinical Oncology by Heikki Joensuu, MD, PhD, of the Comprehensive Cancer Center Helsinki, Finland, and colleagues ...
Heikki Joensuu (@heikkijoensuu)Instagram · heikkijoensuu100+ Follower
www.instagram.com
0 Followers, 122 Following, 43 Posts - See Instagram photos and videos from Heikki Joensuu (@heikkijoensuu) 0 Followers, 122 Following, 43 Posts - See Instagram photos and videos from Heikki Joensuu (@heikkijoensuu)
Heikki Joensuu, MD, on 15-Year Survival of Early Breast ...MedPage Today
www.medpagetoday.com
— ... Heikki Joensuu, MD, of Helsinki University Hospital, and colleagues looked at 15-year overall survival data from the trial, in which — ... Heikki Joensuu, MD, of Helsinki University Hospital, and colleagues looked at 15-year overall survival data from the trial, in which
EXPERT POINT OF VIEW: Eric P. Winer, MD, FASCO ...The ASCO Post
ascopost.com
— Heikki Joensuu, MD. For Heikki Joensuu, MD, Professor of Oncology at the University of Helsinki in Finland, “The issue is — Heikki Joensuu, MD. For Heikki Joensuu, MD, Professor of Oncology at the University of Helsinki in Finland, “The issue is ...
Heikki Joensuuoncology.medicinematters.com
oncology.medicinematters.com
Heikki Joensuu. Contact. address: Department of Oncology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, Helsinki, Finland. print. Heikki Joensuu. Contact. address: Department of Oncology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, Helsinki, Finland. print.
10-year survival results from the randomized FinXX trial.ASCO Publications
ascopubs.org
von H Joensuu · · Zitiert von: 8 — Authors: Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner, Riitta Kokko, Päivi Auvinen ... von H Joensuu · · Zitiert von: 8 — Authors: Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner, Riitta Kokko, Päivi Auvinen ...
A Method for Optimizing the Timing of CT Scans in ...Radiological Society of North America | RSNA
pubs.rsna.org
von H Joensuu · · Zitiert von: 33 — Heikki Joensuu , · Peter Reichardt, · Mikael Eriksson, · Kirsten Sundby Hall, ... von H Joensuu · · Zitiert von: 33 — Heikki Joensuu , · Peter Reichardt, · Mikael Eriksson, · Kirsten Sundby Hall, ...
An effective drug combination for the first-line treatment of ...Annals of Palliative Medicine
apm.amegroups.org
von H Joensuu · — Editorial Commentary. An effective drug combination for the first-line treatment of advanced gastrointestinal stromal tumor. Heikki Joensuu. Article Options. von H Joensuu · — Editorial Commentary. An effective drug combination for the first-line treatment of advanced gastrointestinal stromal tumor. Heikki Joensuu. Article Options.
Verwandte Suchanfragen zu Heikki Joensuu
|
Personen Vorname "Heikki" (221) Name "Joensuu" (12) |
sortiert nach Relevanz / Datum